NCT02942199
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Cambridge Health Alliance Cambridge, Massachusetts, United States
Clinical trial condition
Chemically-Induced Disorders
Explore clinical trials studying Chemically-Induced Disorders. Study availability and eligibility vary by location and protocol.
7,314 public trials
1,008 recruiting studies
Chemically-Induced Disorders trial results
NCT01412866
- Conditions
- Behavior, Chemically-Induced Disorders, Mental Disorders, +7 more
- Locations
-
- Thresholds Psychiatric Rehabilitation Center Chicago, Illinois, United States
Completed
OPAL: "Opiates and PhArmacoLogy"
NCT01847729
- Conditions
- Behavior, Chemically-Induced Disorders, Disruptive, Impulse Control, and Conduct Disorders, +7 more
- Locations
-
- Brest Universit Hospital Brest, France
- CSAPA "La métairie" La Roche-sur-Yon, France
- Morlaix Hospital Morlaix, France
- CSAPA "Le triangle" Nantes, France
NCT01386177
- Conditions
- Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +4 more
- Locations
-
- University Hospital Basel Basel, Switzerland
NCT01270672
- Conditions
- Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +4 more
- Locations
-
- Clinical Pharmacology & Toxicology, University Hospital Basel Basel, Switzerland
NCT00834080
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Alkermes Clinical Study Site Colton, California, United States
- Alkermes Clinical Study Site Oceanside, California, United States
- Alkermes Clinical Study Site Lauderhill, Florida, United States
- Alkermes Clinical Study Site Hoffman Estates, Illinois, United States
NCT00934024
- Conditions
- Behavior, Chemically-Induced Disorders, Mental Disorders, +4 more
- Locations
-
- Medical University of South Carolina Charleston, South Carolina, United States
NCT03765346
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Abuse, +1 more
- Locations
-
- Algorithme Pharma Montreal, Canada
NCT00736255
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +8 more
- Locations
-
- Duke Attention Deficit Hyperactivity Disorder (ADHD) Program Durham, North Carolina, United States
NCT01320748
- Conditions
- Alcohol Abuse, Alcohol-Related Disorders, Alcoholism, +11 more
- Locations
-
- Georgetown Center for Functional And Molecular Imaging, Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Inova Heath Services Comprehensive Addictions Treatment Services (ICATS) Falls Church, Virginia, United States